VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $134,838,000 | +28.6% | 5,801,947 | -11.9% | 0.07% | +13.8% |
| Q1 2018 | $104,812,000 | -35.4% | 6,583,682 | -15.7% | 0.06% | -41.4% |
| Q4 2017 | $162,268,000 | +74.9% | 7,808,896 | +20.6% | 0.10% | +39.4% |
| Q3 2017 | $92,767,000 | +9.6% | 6,473,624 | +32.3% | 0.07% | -1.4% |
| Q2 2017 | $84,665,000 | +109.3% | 4,893,918 | +33.4% | 0.07% | +94.6% |
| Q1 2017 | $40,450,000 | -49.5% | 3,667,326 | -33.6% | 0.04% | -54.3% |
| Q4 2016 | $80,135,000 | -56.6% | 5,518,982 | -26.7% | 0.08% | -56.5% |
| Q3 2016 | $184,830,000 | +540.7% | 7,528,730 | +425.7% | 0.19% | +481.2% |
| Q2 2016 | $28,846,000 | +22.6% | 1,432,262 | +60.1% | 0.03% | +6.7% |
| Q1 2016 | $23,525,000 | -72.4% | 894,494 | +6.7% | 0.03% | -67.7% |
| Q4 2015 | $85,200,000 | +55.1% | 838,169 | +172.2% | 0.09% | +78.8% |
| Q3 2015 | $54,921,000 | -42.6% | 307,887 | -28.5% | 0.05% | -37.3% |
| Q2 2015 | $95,694,000 | +204.1% | 430,765 | +171.9% | 0.08% | +176.7% |
| Q1 2015 | $31,466,000 | -77.9% | 158,423 | -84.1% | 0.03% | -78.6% |
| Q4 2014 | $142,458,000 | +520.2% | 995,443 | +468.6% | 0.14% | +483.3% |
| Q3 2014 | $22,970,000 | +771.1% | 175,077 | +737.4% | 0.02% | +700.0% |
| Q2 2014 | $2,637,000 | -96.8% | 20,907 | -96.7% | 0.00% | -96.9% |
| Q1 2014 | $82,568,000 | +68.4% | 626,322 | +50.0% | 0.10% | +51.6% |
| Q4 2013 | $49,028,000 | +189.2% | 417,611 | +157.0% | 0.06% | +146.2% |
| Q3 2013 | $16,955,000 | -30.0% | 162,508 | -42.2% | 0.03% | -38.1% |
| Q2 2013 | $24,221,000 | – | 281,369 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |